BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 24138526)

  • 1. Looking into the future with bioresorbable vascular scaffolds.
    Costopoulos C; Naganuma T; Latib A; Colombo A
    Expert Rev Cardiovasc Ther; 2013 Oct; 11(10):1407-16. PubMed ID: 24138526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current and future perspectives on drug-eluting bioresorbable coronary scaffolds.
    Ielasi A; Tespili M
    Future Cardiol; 2014 May; 10(3):409-20. PubMed ID: 24976477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Which patients could benefit the most from bioresorbable vascular scaffold implant: from clinical trials to clinical practice.
    Latib A; Costopoulos C; Naganuma T; Colombo A
    Minerva Cardioangiol; 2013 Jun; 61(3):255-62. PubMed ID: 23681128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioresorbable metal scaffold for cardiovascular application: current knowledge and future perspectives.
    Kitabata H; Waksman R; Warnack B
    Cardiovasc Revasc Med; 2014 Mar; 15(2):109-16. PubMed ID: 24684760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioabsorbable scaffolds for the treatment of obstructive coronary artery disease: the next revolution in coronary intervention?
    Patel N; Banning AP
    Heart; 2013 Sep; 99(17):1236-43. PubMed ID: 23474621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioresorbable scaffolds for the treatment of coronary artery disease: current status and future perspective.
    Kraak RP; Grundeken MJ; Koch KT; de Winter RJ; Wykrzykowska JJ
    Expert Rev Med Devices; 2014 Sep; 11(5):467-80. PubMed ID: 25087771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From drug eluting stents to bioresorbable scaffolds; to new horizons in PCI.
    Tenekecioglu E; Bourantas C; Abdelghani M; Zeng Y; Silva RC; Tateishi H; Sotomi Y; Onuma Y; Yılmaz M; Serruys PW
    Expert Rev Med Devices; 2016; 13(3):271-86. PubMed ID: 26782080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioresorbable scaffolds: rationale, current status, challenges, and future.
    Iqbal J; Onuma Y; Ormiston J; Abizaid A; Waksman R; Serruys P
    Eur Heart J; 2014 Mar; 35(12):765-76. PubMed ID: 24366915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design principles and performance of bioresorbable polymeric vascular scaffolds.
    Oberhauser JP; Hossainy S; Rapoza RJ
    EuroIntervention; 2009 Dec; 5 Suppl F():F15-22. PubMed ID: 22100671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The bioresorbable coronary scaffold].
    Hassell ME; van de Hoef TP; Damman P; Delewi R; Serruys PW; Piek JJ
    Ned Tijdschr Geneeskd; 2012; 156(36):A4994. PubMed ID: 22951133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absorb bioresorbable vascular scaffold: What have we learned after 5 years of clinical experience?
    Caiazzo G; Kilic ID; Fabris E; Serdoz R; Mattesini A; Foin N; De Rosa S; Indolfi C; Di Mario C
    Int J Cardiol; 2015 Dec; 201():129-36. PubMed ID: 26298354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioresorbable scaffold technologies.
    Onuma Y; Ormiston J; Serruys PW
    Circ J; 2011; 75(3):509-20. PubMed ID: 21301138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Structure and function of the fully bioresorbable vascular scaffold].
    De Servi S
    G Ital Cardiol (Rome); 2013 Sep; 14(9 Suppl 1):4S-7S. PubMed ID: 24084667
    [No Abstract]   [Full Text] [Related]  

  • 14. Bioresorbable scaffolds: current knowledge, potentialities and limitations experienced during their first clinical applications.
    Bourantas CV; Onuma Y; Farooq V; Zhang Y; Garcia-Garcia HM; Serruys PW
    Int J Cardiol; 2013 Jul; 167(1):11-21. PubMed ID: 22748288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioresorbable scaffolds for coronary artery disease: current status and future prospective.
    Zhang Y; Gao R; Xu B; Cummins P; Serruys PW
    Chin Med J (Engl); 2014; 127(6):1141-8. PubMed ID: 24622448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioresorbable scaffolds: talking about a new interventional revolution [corrected].
    Hassell ME; Grundeken MJ; Delewi R; Wykrzykowska JJ; Piek JJ
    Minerva Cardioangiol; 2013 Apr; 61(2):165-79. PubMed ID: 23492600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Everolimus-eluting ABSORB bioresorbable vascular scaffold: present and future perspectives.
    Brugaletta S; Garcia-Garcia HM; Onuma Y; Serruys PW
    Expert Rev Med Devices; 2012 Jul; 9(4):327-38. PubMed ID: 22420293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. OrbusNeich fully absorbable coronary stent platform incorporating dual partitioned coatings.
    Cottone RJ; Thatcher GL; Parker SP; Hanks L; Kujawa DA; Rowland SM; Costa M; Schwartz RS; Onuma Y
    EuroIntervention; 2009 Dec; 5 Suppl F():F65-71. PubMed ID: 22100679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current status of bioresorbable scaffolds in the treatment of coronary artery disease.
    Wiebe J; Nef HM; Hamm CW
    J Am Coll Cardiol; 2014 Dec; 64(23):2541-51. PubMed ID: 25500240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioresorbable vascular scaffolds in left main coronary artery disease.
    Everaert B; Capranzano P; Tamburino C; Seth A; van Geuns RJ
    EuroIntervention; 2015; 11 Suppl V():V135-8. PubMed ID: 25983148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.